Whitehawk Therapeutics, Inc.
WHWK•NASDAQ•Healthcare•Biotechnology

About Whitehawk Therapeutics

Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides a three-asset antibody-drug conjugate (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in March 2025. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.

Company Information

SectorHealthcare
IndustryBiotechnology
CEODavid Lennon
Founded2007
Employees40
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Websiteir.whitehawktx.com
Phone551 321 2234
Address
2 Headquarters Plaza, East Building Morristown, New Jersey 07960 United States

Corporate Identifiers

CIK0001422142
CUSIP00032Q104
ISINUS00032Q1040
EIN61-1547850
SIC2834

Leadership Team & Key Executives

Dr. David J. Lennon Ph.D.
President, Chief Executive Officer and Director
Dr. Neil P. Desai Ph.D.
Founder and Director
Scott M. Giacobello CPA
Chief Financial Officer, Treasurer, Investor Relations and Corporate Communications
Bryan Ball
Chief Technical Operations Officer
Dr. David Dornan Ph.D.
Chief Scientific Officer
Stephen M. Rodin J.D.
Senior Vice President of Legal and General Counsel
Dr. Margaret Han Dugan M.D.
Chief Medical Officer